Media stories about MGC Diagnostics Corporation (NASDAQ:MGCD) have been trending somewhat positive on Saturday, according to Accern Sentiment Analysis. Accern identifies negative and positive press coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. MGC Diagnostics Corporation earned a media sentiment score of 0.17 on Accern’s scale. Accern also assigned news stories about the medical equipment provider an impact score of 46.484038796509 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

Shares of MGC Diagnostics Corporation (NASDAQ:MGCD) opened at 7.91 on Friday. The firm has a 50-day moving average of $8.04 and a 200 day moving average of $8.38. MGC Diagnostics Corporation has a one year low of $6.24 and a one year high of $10.60. The company’s market cap is $34.80 million.

MGC Diagnostics Corporation (NASDAQ:MGCD) last issued its quarterly earnings results on Thursday, June 1st. The medical equipment provider reported ($0.01) EPS for the quarter. MGC Diagnostics Corporation had a positive return on equity of 0.26% and a negative net margin of 10.22%. The company had revenue of $9.82 million during the quarter. Equities research analysts anticipate that MGC Diagnostics Corporation will post $0.06 EPS for the current year.

COPYRIGHT VIOLATION WARNING: This news story was reported by Watch List News and is the property of of Watch List News. If you are reading this news story on another website, it was illegally stolen and republished in violation of U.S. and international copyright and trademark law. The correct version of this news story can be accessed at

MGC Diagnostics Corporation Company Profile

MGC Diagnostics Corporation is a medical technology company, which offers cardiorespiratory health solutions. The Company designs, markets and sells non-invasive cardiorespiratory diagnostic products. It sells its products internationally through distributors and in the United States through a direct sales force targeting specialists located in hospitals, university-based medical centers, medical clinics, physician offices, pharmaceutical companies, medical device manufacturers and clinical research organizations (CROs).

Insider Buying and Selling by Quarter for MGC Diagnostics Corporation (NASDAQ:MGCD)

Receive News & Ratings for MGC Diagnostics Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MGC Diagnostics Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.